Genicular Artery Embolization for Reducing Pain in Symptomatic Knee Osteoarthritis: A Pilot randomly assigned Sham-Controlled Study (SHAM-PAIN) is a NIH-NIAMS funded project designed to assess enrollment feasibility and detect any differences between GAE and a similar sham intervention in reducing KOA-related pain at 3 months as measured by the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscore. Additionally, this study aims to determine the magnitude of difference in pain response between GAE and sham to adequately power a larger, more definitive randomly assigned sham-controlled trial (RCT).
Official registry: https://clinicaltrials.gov/study/NCT06859164 · University of Utah · enrollment listed as 40
Phase 2: researchers already know a roughly safe dose (from phase 1). This stage asks whether the treatment actually helps the condition, and watches side effects more closely.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
If you join, the listed intervention(s) are Genicular Artery Embolization, Lipiodol, or Simple angiogram. The registry lists allocation as randomized. Genicular Artery Embolization for Reducing Pain in Symptomatic Knee Osteoarthritis: A Pilot randomly assigned Sham-Controlled Study (SHAM-PAIN) is a NIH-NIAMS funded project designed to assess enrollment feasibility and detect any differences between GAE and a similar sham intervention in reducing KOA-related pain at 3 months as measured by the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscore.
They plan to enroll about 40 people at Salt Lake City. Taking part typically means using or being fitted with a device, a procedure as part of the study plus check-ins.
Genicular Artery Embolization for Reducing Pain in Symptomatic Knee Osteoarthritis: A Pilot Randomized Sham-Controlled Study
Interventions: Genicular Artery Embolization, Lipiodol, Simple angiogram
Primary outcome (registry wording): Reduction in KOOS pain subscore
Osman Ahmed, MD
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
This study wants to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.
NCT04210284 · Official ClinicalTrials.gov record · NYU Langone Health
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern.
NCT04375280 · Official ClinicalTrials.gov record · University Hospital, Clermont-Ferrand
A multi-center randomly assigned compared with a dummy treatment clinical trial which determines the how well it works of trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb. The primary outcome is patient reported evaluation of pain and function of the wrist and hand at 6 months after the randomization to treatment group.
NCT05127005 · Official ClinicalTrials.gov record · Tampere University Hospital
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
Phase 2. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary